Refractory hypertension.
D000284:Administration, Oral; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002908:Chronic Disease; D003981:Diazoxide / Q000009:adverse effects / Q000627:therapeutic use; D004338:Drug Combinations; D004351:Drug Resistance; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006943:Hyperglycemia / Q000139:chemically induced; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007275:Injections, Intravenous; D007676:Kidney Failure, Chronic / Q000209:etiology; D008914:Minoxidil / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000959:Antihypertensive Agents; D004338:Drug Combinations; D007004:Hypoglycemic Agents; D014665:Vasodilator Agents; D006830:Hydralazine; D008914:Minoxidil; D003981:Diazoxide